Urine risk factors in children with calcium kidney stones and their siblings

Kidney International

Volumn 81, Issue 11, 2012, Pages 1140-1148

  Bergsland, Kristin J ^a   Coe, Fredric L ^a   White, Mark D ^b   Erhard, Michael J ^c   Defoor, William R ^d   Mahan, John D ^e   Schwaderer, Andrew L ^e   Asplin, John R ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c NEMOURS CHILDREN S CLINIC   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f LithoLink Corporation   (United States)

Author keywords

calcium oxalate; hypercalciuria; kidney calculi

Indexed keywords

CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE;

ADOLESCENT; ARTICLE; BODY SIZE; CALCIUM EXCRETION; CALCIUM STONE; CALCIUM URINE LEVEL; CHILD; CHILD HEALTH; CONTROLLED STUDY; CRYSTALLIZATION; FEMALE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPOCITRATURIA; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PH MEASUREMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SIBLING; URINALYSIS; URINE PH; URINE VOLUME;

EID: 84861182066     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.7     Document Type: Article

References (49)

1. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med 2010; 363: 954-963.
2. Pak CY. Medical management of urinary stone disease. Nephron Clin Pract 2004; 98: c49-c53. (Pubitemid 39452105)
3. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med 1979; 300: 337-340. (Pubitemid 9114886)
4. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2010; 25: 831-841.
5. Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res 1997; 12: 522-533. (Pubitemid 27155211)
6. Tiselius HG. Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC et al. (eds). Kidney Stones: Medical and Surgical Management Lippincott-Raven: Philadelphia, 1996, pp 33-64.
7. Grover PK, Marshall VR, Ryall RL. Dissolved urate salts out calcium oxalatein undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol 2003; 10: 271-278. (Pubitemid 36380284)
8. Lau KK. Clinical manifestations of pediatric idiopathic hypercalciuria. Front Biosci (Elite Ed) 2009; 1: 52-59.
9. Stapleton FB. Clinical approach to children with urolithiasis. Semin Nephrol 1996; 16: 389-397.
10. Alon US, Zimmerman H, Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited. Pediatr Nephrol 2004; 19: 516-520. (Pubitemid 38594289)
11. MacDougall L, Taheri S, Crofton P. Biochemical risk factors for stone formation in a Scottish paediatric hospital population. Ann Clin Biochem 2010; 47: 125-130.
12. DeFoor W, Minevich E, Jackson E et al. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol 2008; 179: 2369-2372.
13. DeFoor W, Asplin J, Jackson E et al. Urinary metabolic evaluations in normal and stone forming children. J Urol 2006; 176: 1793-1796. (Pubitemid 44308481)
14. Alpay H, Ozen A, Gokce I et al. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24: 2203-2209.
15. Spivacow FR, Negri AL, Del Valle EE et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-1133.
16. Brown CM, Purich DL. Physical-chemical processes in kidney stone formation. In: Coe FL, Favus MJ (eds). Disorders of Bone and Mineral Metabolism. Raven Press: New York, 1992, pp 613-624.
17. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997; 51: 894-900. (Pubitemid 27157979)
18. Bartosh SM. Medical management of pediatric stone disease. Urol Clin North Am 2004; 31: 575-587. (Pubitemid 39093941)
19. Evan AP, Coe FL, Lingeman JE et al. Mechanism of formation of human calcium oxalate renal stones on Randall0s plaque. Anat Rec (Hoboken) 2007; 290: 1315-1323. (Pubitemid 47573203)
20. Hess B, Kok DJ. Nucleation, growth, and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC et al. (eds). Kidney Stones: Medical and Surgical Management. Lippincott-Raven: Philadelphia, 1996, pp 3-32.
21. Asplin JR, Parks JH, Coe FL. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 1997; 52: 1602-1608. (Pubitemid 28032064)
22. Pak CY, Galosy RA. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score. Am J Med 1980; 69: 681-689.
23. Nicar MJ, Hill K, Pak CY. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. Metabolism 1983; 32: 906-910. (Pubitemid 13051141)
24. Asplin JR, Parks JH, Chen MS et al. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 1999; 56: 1505-1516. (Pubitemid 29451257)
25. Asplin JR, Parks JH, Nakagawa Y et al. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int 2002; 61: 1821-1829. (Pubitemid 34437937)
26. Hesse A, Wuzel H, Vahlensieck W. Significance of glycosaminoglycans for the formation of calcium oxalate stones. Am J Kidney Dis 1991; 17: 414-419.
27. Hedgepeth RC, Yang L, Resnick MI et al. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals. Am J Kidney Dis 2001; 37: 104-112. (Pubitemid 32055025)
28. Bergsland KJ, Kelly JK, Coe BJ et al. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol 2006; 291: F530-F536. (Pubitemid 44343734)
29. Bergsland KJ, Kinder JM, Asplin JR et al. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 2002; 167: 2372-2376. (Pubitemid 34533128)
30. Hess B, Nakagawa Y, Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 1989; 257: F99-106.
31. Grover PK, Moritz RL, Simpson RJ et al. Inhibition of growth and aggregation of calcium oxalate crystals in vitro-a comparison of four human proteins. Eur J Biochem 1998; 253: 637-644. (Pubitemid 28223529)
32. Atmani F, Khan SR. Role of urinary bikunin in the inhibition of calcium oxalate crystallization. J Am Soc Nephrol 1999; 10(Suppl): 14:S385-14:S388.
33. Schwille PO, Schmiedl A, Herrmann U et al. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis. Urol Res 1999; 27: 117-126. (Pubitemid 29227322)
34. Miyake O, Yoshimura K, Tsujihata M et al. Possible causes for the low prevalence of pediatric urolithiasis. Urology 1999; 53: 1229-1234. (Pubitemid 29264760)
35. Nicar MJ, Hill K, Pak CY. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. J Bone Miner Res 1987; 2: 215-220.
36. Pearle MS, Calhoun E, Curhan GC. Urolithiasis, chapter 8. In: Litwin MS, Saigal CS (eds) Urologic Diseases in America. (US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 07-5512) US Government Printing Office: Washington, DC, 2007, pp 283-319.
37. Tanaka ST, Pope JC. Pediatric stone disease. Curr Urol Rep 2009; 10: 138-143.
38. Worcester EM, Coe FL. Nephrolithiasis. Prim Care 2008; 35: 369-391, vii. (Pubitemid 351680115)
39. Coe FL, Parks JH. Nephrolithiasis: Pathogenesis and Treatment. 2nd ed. Year Book Medical Publishers: Chicago, 1988, p 34.
40. Licata AA, Bou E, Bartter FC et al. Effects of dietary protein on urinary calcium in normal subjects and in patients with nephrolithiasis. Metabolism 1979; 28: 895-900. (Pubitemid 9256917)
41. Mei Z, Grummer-Strawn LM, Pietrobelli A et al. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 2002; 75: 978-985. (Pubitemid 34547525)
42. Eisner BH, Eisenberg ML, Stoller ML. Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. J Urol 2009; 182: 1142-1145.
43. Tefekli A, Esen T, Ziylan O et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 2003; 70: 273-277. (Pubitemid 36566256)
44. Tekin A, Tekgul S, Atsu N et al. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol 2000; 164: 162-165. (Pubitemid 30434295)
45. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115: 2598-2608. (Pubitemid 41434382)
46. Borghi L, Meschi T, Schianchi T et al. Urine volume: stone risk factor and preventive measure. Nephron 1999; 81(Suppl 1): 31-37. (Pubitemid 29015465)
47. Nouvenne A, Meschi T, Prati B et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr 2010; 91: 565-570.
48. Asplin J, Parks J, Lingeman J et al. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol 1998; 159: 1821-1825. (Pubitemid 29190704)
49. Werness PG, Brown CM, Smith LH et al. EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 1985; 134: 1242-1244. (Pubitemid 16207045)